))
S3 E4 – “No ‘One Type Fits All’ in Lung Cancer Treatment”: An Interview with Dr Anne-Marie Baird (Lung Cancer Europe)
Manage episode 407172572 series 3558520
Content provided by Karger Publishers. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Karger Publishers or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
For this episode of Karger’s The Waiting Room Podcast, we spoke again with Dr Anne-Marie Baird, who currently serves as the president of Lung Cancer Europe (LuCE). She is a Senior Research Fellow at Trinity College Dublin, Ireland, and a patient advocate. In this episode we are going to focus on non-small cell lung cancer, genetic predisposition, biomarkers and treatment.
More information on lung cancer is freely available here:
- Fast Facts for Patients: Non-small Cell Lung Cancer with KRAS Mutation
- Infographic Summary Sheets for Patients:
KRAS G12C in Metastatic Non-Small Cell Lung Cancer
When Checkpoint Inhibitor Therapy Stops Working
Biomarkers in Metastatic Non-Small Cell Lung Cancer
For more podcast episodes from Karger please visit https://www.karger.com/pages/podcasts.
40 episodes
Share
